Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.00% | -15.00% | 0.00% | -6.81% | 0.00% |
Total Receivables | 0.00% | -70.49% | 0.00% | 914.53% | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 0.00% | 2.53% | 0.00% | -45.49% | 0.00% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | -- | -- | -- | 0.00% |
Total Current Assets | 0.00% | -16.34% | 0.00% | -5.43% | 0.00% |
|
|||||
Total Current Assets | 0.00% | -16.34% | 0.00% | -5.43% | 0.00% |
Net Property, Plant & Equipment | 0.00% | -6.24% | 0.00% | -4.58% | 0.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | -7.02% | 0.00% | -8.06% | 0.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -65.63% | 0.00% | 300.00% | 0.00% |
Total Assets | 0.00% | -16.00% | 0.00% | -5.34% | 0.00% |
|
|||||
Total Accounts Payable | 0.00% | -94.00% | 0.00% | 158.08% | 0.00% |
Total Accrued Expenses | 0.00% | 139.17% | 0.00% | -66.39% | 0.00% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 0.00% | -38.89% | 0.00% | -11.58% | 0.00% |
Total Finance Division Other Current Liabilities | 0.00% | -19.49% | 0.00% | -96.17% | 0.00% |
Total Other Current Liabilities | 0.00% | -19.49% | 0.00% | -96.17% | 0.00% |
Total Current Liabilities | 0.00% | -12.07% | 0.00% | -61.95% | 0.00% |
|
|||||
Total Current Liabilities | 0.00% | -12.07% | 0.00% | -61.95% | 0.00% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 0.00% | -67.12% | 0.00% | -59.44% | 0.00% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 0.00% | 60.41% | 0.00% | -2.72% | 0.00% |
Total Liabilities | 0.00% | -9.64% | 0.00% | -61.01% | 0.00% |
|
|||||
Common Stock & APIC | 0.00% | -30.14% | 0.00% | 45.44% | 0.00% |
Retained Earnings | 0.00% | 35.05% | 0.00% | -61.25% | 0.00% |
Treasury Stock & Other | 0.00% | -113.88% | 0.00% | 1,219.19% | 0.00% |
Total Common Equity | 0.00% | -16.58% | 0.00% | 8.85% | 0.00% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 0.00% | -16.58% | 0.00% | 8.85% | 0.00% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 0.00% | -16.58% | 0.00% | 8.85% | 0.00% |
|